Patient info Search Menu

Co-amoxiclav 875 mg / 125 mg film-coated tablets – patient leaflet, side effects, dosage

Status:
Prescription only (POM) Key facts
Medicine strength:
875 mg / 125 mg
Contains active substances:

Patient leaflet - Co-amoxiclav 875 mg / 125 mg film-coated tablets

1. What Co-amoxiclav Tablets is and what it is used for

Co-amoxiclav is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called “penicillins” that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening.

Co-amoxiclav is used in adults and children to treat the following infections:

  • middle ear and sinus infections
  • respiratory tract infections
  • urinary tract infections
  • skin and soft tissue infections including dental

    infections

  • bone and joint infections.

2. What you need to know before you take Co-amoxiclav Tablets

Do not take Co-amoxiclav:

  • if you are allergic to amoxicillin, clavulanic acid,

    penicillins or any of the other ingredients of this medicine (listed in section 6)

    Package leaflet: Information for the user

    Co-amoxiclav 875mg/125mg film-coated Tablets

    If you are taking allopurinol (used for gout) with Co-amoxiclav, it may be more likely that you will have an allergic skin reaction.

    If you are taking probenecid (used for gout), your doctor may decide to adjust your dose of Co-amoxiclav.

    If medicines to help stop blood clots (such as warfarin) are taken with Co-amoxiclav Tablets then extra blood tests may be needed.

    Co-amoxiclav can affect how methotrexate (a medicine used to treat cancer or rheumatic diseases) works.

    Co-amoxiclav can affect how mycophenolate mofetil (a medicine used to prevent the rejection of transplanted organs) works.

    This medicine contains 0.63 mmol (or 24.632 mg) potassium per tablet. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.

    Pregnancy and breast-feeding

    If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

    Driving and using machines

    Co-amoxiclav can have side effects and the symptoms may make you unfit to drive. Don't drive or operate machinery unless you are feeling well.

3. How to take Co-amoxiclav Tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Adults and children weighing 40 kg and over

Usual dose - 1 tablet two times a day

Higher dose - 1 tablet three times a day

Children weighing less than 40 kg

Children aged 6 years or less should preferably be treated with Co-Amoxiclav oral suspension or sachets.

Ask your doctor or pharmacist for advice when giving Co-amoxiclav tablets to children weighing less than 40 kg. The tablets are not suitable for children weighing less than 25 kg.

Patients with kidney and liver problems

  • If you have kidney problems the dose might be

    changed. A different strength or a different medicine may be chosen by your doctor. · If you have liver problems you may have more

    frequent blood tests to check how your liver is working.

    How to take Co-amoxiclav Tablets

    • Swallow the tablets whole with a glass of water

      with a meal.

    • Space the doses evenly during the day, at least

      4 hours apart. Do not take 2 doses in 1 hour. · Do not take Co-amoxiclav for more than

      2 weeks. If you still feel unwell you should go back to see the doctor.

If you take more Co-amoxiclav Tablets than you should

If you take too much Co-amoxiclav, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions. Talk to your doctor as soon as possible. Take the medicine carton or bottle to show the doctor.

If you forget to take Co-amoxiclav Tablets

If you forget to take a dose, take it as soon as you remember. You should not take the next dose too soon, but wait about 4 hours before taking the next dose.

Do not take a double dose to make up for a forgotten dose.

If you stop taking Co-amoxiclav Tablets

Keep taking Co-amoxiclav until the treatment is finished, even if you feel better. You need every dose to help fight the infection. If some bacteria survive they can cause the infection to come back.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Conditions you need to look out for

Allergic reactions:

  • skin rash
  • inflammation of blood vessels (vasculitis) which

    may be visible as red or purple raised spots on the skin, but can affect other parts of the body · fever, joint pain, swollen glands in the neck,

    armpit or groin

  • swelling, sometimes of the face or throat

    (angioedema), causing difficulty in breathing · collapse.

  • chest pain in the context of allergic reactions,

    which may be a symptom of allergy triggered cardiac infarction (Kounis syndrome)

Warning: Allergic reactions can sometimes occur delayed.

Contact a doctor immediately if you get any of these symptoms. Stop taking Co-amoxiclav Tablets.

Inflammation of large intestine

Inflammation of the large intestine, causing watery diarrhoea usually with blood and mucus, stomach pain and/or fever.

Acute inflammation of the pancreas (acute pancreatitis)

If you have severe and on-going pain in the stomach area this could be a sign of acute pancreatitis.

Drug-induced enterocolitis syndrome (DIES): DIES has been reported mainly in children receiving amoxicillin/clavulanic acid. It is a certain kind of allergic reaction with the leading symptom of repetitive vomiting (1-4 hours after drug administration). Further symptoms could comprise abdominal pain, lethargy, diarrhoea and low blood pressure.

Contact your doctor as soon as possible for advice if you get these symptoms.

Very common side effects

These may affect more than 1 in 10 people · diarrhoea (in adults).

Common side effects

These may affect up to 1 in 10 people · thrush (candida - a yeast infection of the

vagina, mouth or skin folds)

  • feeling sick (nausea), especially when taking

    high doses

If affected take Co-amoxiclav with a meal · vomiting.

  • Diarrhoea (in children)

Uncommon side effects

These may affect up to 1 in 100 people · skin rash, itching

  • raised itchy rash (hives)
  • indigestion
  • dizziness
  • headache.

Uncommon side effects that may show up in your blood tests:

  • increase in some substances (enzymes)

    produced by the liver

Rare side effects

These may affect up to 1 in 1000 people · skin rash, which may blister, and looks like

small targets (central dark spots surrounded by a paler area, with a dark ring around the edge-erythema multiforme)

If you notice any of these symptoms contact a doctor urgently.

Rare side effects that may show up in your blood tests:

  • low number of cells involved in blood clotting
  • low number of white blood cells.

Frequency not known

Frequency cannot be estimated from the available data.

  • Allergic reactions (see above)
  • Inflammation of the large intestine (see above) · Serious skin reactions:

    • a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form causing extensive peeling of the skin (more than 30% of the body surface – toxic epidermal necrolysis)
    • widespread red skin rash with small pus-containing blisters (bulloous exfoliative dermatitis)
    • a red, scaly rash with bumps under the skin and blisters (exanthemous pustulosis). · flu-like symptoms with a rash, fever, swollen glands, and abnormal blood test results (including increased white blood cells (eosinophilia) and liver enzymes) (Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS))
    • a red rash commonly seen on both sides of buttocks, upper inner thighs, armpits, neck (Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)).
  • Inflammation of the membranes that surround the brain and spinal cord (aseptic meningitis)

Contact a doctor immediately if you get any of these symptoms:

  • Rash with blisters arranged in a circle with central crusting or like a string of pearls (linear IgA disease)
  • inflammation of the liver (hepatitis) · jaundice, caused by increases in the blood of bilirubin (a substance produced in the liver) which may make your skin and whites of eyes appear yellow
  • inflammation of tubes in the kidney · blood takes longer to clot
  • hyperactivity
  • convulsions (in people taking high doses of Co-amoxiclav or who have kidney problems) · black tongue which looks hairy

Side effects that may show up in your blood or urine tests:

  • severe reduction in the number of white blood cells
  • low number of red blood cells (haemolytic anaemia)
  • crystals in urine leading to acute kidney injury.

3

2

150 mm

120 mm

Size: 270(L) x 250(W) mm

Front side

Size: 270(L) x 250(W) mm

Back side

(Amoxicillin/clavulanic acid)

Co-amoxiclav film-coated Tablets - BBUK

875/125 mg

Leaflet

270(L) x 250(W) mm

NA

NA

Arial Narrow, 9 pt

01

Colours not for Printing

Code No. :

WOA

WA

Reason for Change 1) Product :

  1. 2) Strength :
  2. 3) Component :
  3. 4) No of colours :
  4. 5)

    Dimension :

    Revision: 00

    Date: 16-09-2025

    NA

Contract Giver/ PL holder

Head QA (Site) Head Production/ Packing (Site)

Affairs

Department

Sign / Date

NA

NA

  • if you have ever had a severe allergic reaction

    to any other antibiotic. This can include a skin rash or swelling of the face or throat. · if you have ever had liver problems or jaundice

    (yellowing of the skin) when taking an antibiotic.

Do not take Co-amoxiclav if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Co-amoxiclav Tablets.

Warnings and precautions

Talk to your doctor or pharmacist before taking Co-amoxiclav Tablets if you:

  • have glandular fever
  • are being treated for liver or kidney problems · are not passing water regularly.

If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking these tablets.

In some cases, your doctor may investigate the type of bacteria that is causing your infection. Depending on the results, you may be given a different strength of Co-amoxiclav or a different medicine.

Conditions you need to look out for:

Co-amoxiclav can make some existing conditions worse, or cause serious side effects. These include allergic reactions, convulsions (fits) and

inflammation of the large intestine. You must look out for certain symptoms while you are taking Co-amoxiclav, to reduce the risk of any problems. See 'Conditions you need to look out for' in Section 4.

Blood and urine tests:

If you are having blood tests (such as red blood cell status tests or liver function tests) or urine tests (for glucose), let the doctor or nurse know that you are taking Co-amoxiclav. This is because Co-amoxiclav can affect the results of these types of tests.

Other medicines and Co-amoxiclav Tablets

Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines. This includes medicines that can be bought without a prescription and herbal medicines. Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.

United Kingdom

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store

Ireland

HPRA Pharmacovigilance

Earlsfort Terrace

IRL - Dublin 2

Tel: +353 1 6764971

Fax: +353 1 6762517

Website: www.hpra.ie

e-mail: medsafety@hpra.ie

5. How to store Co-amoxiclav Tablets

Keep this medicine out of the sight and reach of children.

Do not store above 25°C. Store in the original package in order to protect from light and moisture.

Do not take this medicine after the expiry date which is stated on the carton and blister strip after EXP. The expiry date refers to the last day of that month.

Do not take this medicine if you notice any visible signs of deterioration.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Co-amoxiclav Tablets contains:

  • The active substances are Amoxicillin

    Trihydrate and Potassium Clavulanate., Diluted

Each film-coated tablet contains 875mg amoxicillin as amoxicillin trihydrate and 125mg of clavulanic acid as potassium clavulanate, diluted.

  • The other ingredients are:

Cellulose, microcrystalline (E460)

Sodium starch glycolate, Type A

Silica, Colloidal anhydrous (E551)

Magnesium Stearate (E470b)

1

4

Film coat

Titanium dioxide (E171)

Hypromellose (E464)

Propylene glycol (E1520)

Talc (E553b)

Ethyl cellulose

What Co-amoxiclav looks like and contents of the pack

White, capsule-shaped film-coated tablet, debossed with 'I 07' on one side and plain on the other.

The tablets are packaged in aluminium blisters consisting of: 4, 5, 6, 7, 8, 10, 12, 14, 15, 16, 20, 21, 24, 25, 30, 35, 40, 50, 100 & 500 tablets

Not all pack sizes may be marketed

Marketing Authorisation Holder

Brown & Burk UK Ltd

5 Marryat Close

Hounslow West

Middlesex

TW4 5DQ

UK.

Manufacturer

Brown & Burk UK Ltd

5 Marryat Close

Hounslow West

Middlesex

TW4 5DQ

UK.

Misom Labs Limited

Malta Life Sciences Park,

LS2.01.06, Industrial Estate,

San Gwann, SGN 3000,

Malta

This medicinal product is authorised in the Member States of the EEA under the following names:

UK & IE: Co-amoxiclav 875mg/125mg Film- coated Tablets

SE: Amoxicillin/ Clavulanic acid BB 875mg/125mg filmdragerade tabletter DE & AT: Amoxicillin/Clavulansäure Micro Labs

875 mg/125 mg Filmtabletten

This leaflet was last approved on 09/2025.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 25298/0009

MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Co-amoxiclav 875 mg / 125 mg film-coated tablets

What these facts mean

Prescription needed?? Yes, prescription-only medicine (POM)
Active substances? Amoxicillin, Clavulanic acid
Strength? 875 mg / 125 mg
Pharmaceutical form? Oral tablet
White colored capsule shaped film coated tablet debossed with ‘I 07’ on one side and plain on other side. Tablet length = 21.70 ± 0.10mm
How is it taken? Oral
Excipients? Cellulose, microcrystalline (E460), Sodium starch glycolate, Type A, Silica, Colloidal anhydrous (E551), Magnesium Stearate (E470b), Titanium dioxide (E171), Hypromellose (E464), Propylene glycol (E1520), Talc (E553b), Ethyl cellulose
Pack sizes 14 tablet
Is it available?? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life? 2 Years
Storage Do not store above 25°C. Store in the original package in order to protect from light and moisture.
Drug group (ATC)? Combinations of penicillins, incl. beta-lactamase inhibitors
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01C Beta-lactam antibacterials, penicillins
        1. J01CR Combinations of penicillins, incl. beta-lactamase inhibitors
          1. J01CR02 amoxicillin and beta-lactamase inhibitor
Marketing authorisation? PL 25298/0009 (first authorised 17 November 2022)
Marketing authorisation holder? Brown & Burk UK Ltd
Codes? GTIN 5060124640693 · BNF 05010103

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.